Edesa Biotech, Inc.NASDAQ: EDSA

Edesa Biotech to Present at H.C. Wainwright & Co. 6th Annual Israel Conference

· Issued by Edesa Biotech, Inc. via ACCESS Newswire

TORONTO, ON / ACCESSWIRE / November 6, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to present at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020 at 12:30 pm ET.

Edesa senior management will be available during the conference for one-on-one meetings. Members of the investment community who are interested in meeting with the company should contact conference coordinators to arrange an appointment or contact Edesa directly via email at [email protected].

About Edesa Biotech, Inc.Edesa Biotech, Inc. (NASDAQ:EDSA) is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05 and EB01, are in later-stage clinical studies. EB05 is a monoclonal antibody therapy that we are developing as a treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients. ARDS is a life-threatening form of respiratory failure, and the leading cause of death among COVID-19 patients. Edesa is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. The company is based in Markham, Ontario, Canada, with a U.S. subsidiary located in Southern California. Sign up for news alerts.

CONTACT:Gary KoppenjanEdesa Biotech, Inc.(805) 488-2800 ext. 150[email protected]

SOURCE: Edesa Biotech

View source version on accesswire.com: https://www.accesswire.com/615047/Edesa-Biotech-to-Present-at-HC-Wainwright-Co-6th-Annual-Israel-Conference

View original source (ACCESS Newswire)Edesa Biotech, Inc. on 6ix

Earlier from Edesa Biotech

Later from Edesa Biotech

All Edesa Biotech news releases